Literature DB >> 29682256

Identification of oral risk factors for chronic graft versus host disease in haematological patients who underwent allogeneic haematopoietic stem cell transplantation.

A Picardi1, M Miranda2, F Liciani2, G Paterno1, W Arcese1, P Bollero2.   

Abstract

OBJECTIVE: The aim of this prospective observational study was to identify local risk factors for the development of clinical manifestations of oral chronic Graft versus Host Disease (cGvHD) in a cohort of patients affected by haematological malignant diseases who underwent allogeneic haematopoietic stem cell transplantation (HSCT).
MATERIALS AND METHODS: In the context of an active collaboration between the Rome Transplant Network of the Hematology and the Oral Pathology Division at "Policlinico Tor Vergata", in Rome, 47 haematological patients were included in this trial based on a systematic dental screening and follow-up protocol. The dental checks were planned 1 month before the transplant procedure while the subsequent follow ups were scheduled on day +100, +180, +365 and + 730 after the transplant. The tool used for the dental checks was a detailed report including all the potential oral features responsible of mechanical, chemical or infective injuries, except for the drugs.
RESULTS: Overall, 64% of patients (N=30) did not perform dental hygiene during the screening pre-transplant and 53% (25/47) developed cGvHD with oral involvement. The most part of patients (84%) who experienced oral manifestations of cGvHD during the follow-up period after HSCT did not perform dental hygiene before the transplant procedure. Moreover, the comparison between the "presence" or "absence" of dental hygiene before the allogeneic HSCT showed a statistical significant increasing during the follow-up period in the occurrence of oral lesions due to the cGvHD for patients who lack pre-transplant dental care (p=0.029).On the contrary, the frequency of the other factors such as malocclusions, fractured teeth, incongruous prosthesis, food, smoke, alcol and bad habits, resulted similar between the group with or without typical oral lesions of cGvHD.
CONCLUSIONS: The prevention of oral infectious complications provided by primary and secondary dental cares can result in a great benefit for haematological patients who underwent allogeneic HSCT. The combined hematological and dental management represents a clinical need before and after allogeneic HSCT for the removal of inconvenient issues with impact on the short and long-term outcome. Poor dental hygiene seems to be a local risk factor for the development of oral lesions due to cGvHD. However, a larger cohort of patients is necessary to confirm these preliminary data and to evaluate the best preventive and therapeutic oral hygiene protocol in this specific setting.

Entities:  

Keywords:  allogeneic HSCT; cGvHD; dental hygiene; oral lesions

Year:  2017        PMID: 29682256      PMCID: PMC5892662          DOI: 10.11138/orl/2017.10.4.390

Source DB:  PubMed          Journal:  Oral Implantol (Rome)        ISSN: 1974-5648


  24 in total

Review 1.  Prevention of graft-vs.-host disease.

Authors:  Andrew R Rezvani; Rainer F Storb
Journal:  Expert Opin Pharmacother       Date:  2012-07-07       Impact factor: 3.889

2.  Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.

Authors:  Maria Cristina Tirindelli; Gerardo Paolo Flammia; Pierluigi Bove; Raffaella Cerretti; Laura Cudillo; Gottardo De Angelis; Alessandra Picardi; Ombretta Annibali; Carolina Nobile; Elisabetta Cerchiara; Teresa Dentamaro; Paolo De Fabritiis; Alessandro Lanti; Angelo Salvatore Ferraro; Federico Sergi; Fabio Di Piazza; Giuseppe Avvisati; William Arcese
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-20       Impact factor: 5.742

3.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Authors:  Madan H Jagasia; Hildegard T Greinix; Mukta Arora; Kirsten M Williams; Daniel Wolff; Edward W Cowen; Jeanne Palmer; Daniel Weisdorf; Nathaniel S Treister; Guang-Shing Cheng; Holly Kerr; Pamela Stratton; Rafael F Duarte; George B McDonald; Yoshihiro Inamoto; Afonso Vigorito; Sally Arai; Manuel B Datiles; David Jacobsohn; Theo Heller; Carrie L Kitko; Sandra A Mitchell; Paul J Martin; Howard Shulman; Roy S Wu; Corey S Cutler; Georgia B Vogelsang; Stephanie J Lee; Steven Z Pavletic; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-18       Impact factor: 5.742

4.  The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy.

Authors:  Alessandra Picardi; William Arcese; Simona Pollichieni; Fabio Di Piazza; Ilaria Mangione; Anna Maria Gallina; Raffaella Cerretti; Laura Cudillo; Gottardo De Angelis; Andrea Mengarelli; Teresa Dentamaro; Maria Cristina Tirindelli; Anna Chierichini; Antonella Ferrari; Renato Marciano; Marco Andreani; Francesca Bonifazi; Nicoletta Sacchi
Journal:  Transfusion       Date:  2017-06-13       Impact factor: 3.157

5.  Weight loss and malnutrition in patients with chronic graft-versus-host disease.

Authors:  D A Jacobsohn; J Margolis; J Doherty; V Anders; G B Vogelsang
Journal:  Bone Marrow Transplant       Date:  2002-02       Impact factor: 5.483

6.  Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry.

Authors:  Roel J W van Kampen; Carmen Canals; Harry C Schouten; Arnon Nagler; Kirsty J Thomson; Jean-Paul Vernant; Agnes Buzyn; Marc A Boogaerts; Jian-Jian Luan; Sébastien Maury; Noel J Milpied; Jean-Pierre Jouet; Gert J Ossenkoppele; Anna Sureda
Journal:  J Clin Oncol       Date:  2011-02-14       Impact factor: 44.544

7.  Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.

Authors:  Yasuo Morishima; Koichi Kashiwase; Keitaro Matsuo; Fumihiro Azuma; Satoko Morishima; Makoto Onizuka; Toshio Yabe; Makoto Murata; Noriko Doki; Tetsuya Eto; Takehiko Mori; Koichi Miyamura; Hiroshi Sao; Tatsuo Ichinohe; Hiroo Saji; Shunichi Kato; Yoshiko Atsuta; Keisei Kawa; Yoshihisa Kodera; Takehiko Sasazuki
Journal:  Blood       Date:  2014-12-17       Impact factor: 22.113

8.  Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant.

Authors:  Alessandra Picardi; Alessandro Lanti; Laura Cudillo; Raffaella Cerretti; Teresa Dentamaro; Gottardo De Angelis; Angelo Ferraro; Ambra Di Veroli; Gaspare Adorno; William Arcese
Journal:  Transfusion       Date:  2009-10-09       Impact factor: 3.157

Review 9.  Allogeneic haematopoietic stem cell transplantation in myelodysplastic syndromes.

Authors:  Emily Bart-Smith; Ghulam J Mufti
Journal:  Curr Opin Oncol       Date:  2014-11       Impact factor: 3.645

Review 10.  Advances in graft-versus-host disease biology and therapy.

Authors:  Bruce R Blazar; William J Murphy; Mehrdad Abedi
Journal:  Nat Rev Immunol       Date:  2012-05-11       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.